Cited by 4,481Cancer Genomics and DiagnosticsBioinformatics and Genomic NetworksGenetics, Bioinformatics, and Biomedical Research

Visualizing and interpreting cancer genomics data via the Xena platform

Open access
Goldman, Mary J., Craft, Brian, Hastie, Mim, Repečka, Kristupas, McDade, Fran, Kamath, Akhil, Banerjee, Ayan, Luo, Yunhai +4 more·2020·Nature Biotechnology

Published version of a preprint

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-020-0546-8

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • TCGA datasets revealed no significant difference in Paneth-like gene signature expression between SMAD4 wild-type and mutant CRCs.

    “Analysis of The Cancer Genome Atlas (TCGA) datasets revealed no significant difference in Paneth-like gene signature expression between SMAD4 wild-type and mutant CRCs (Figure S5M).54”

    From Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer (2026) · cites this paper as [54]

    The 'To the Editor' section says Xena hosts TCGA datasets and supports gene-expression and mutation data, consistent with its use as a resource for the citing authors’ analysis. It does not report a comparison of Paneth-like signature expression between SMAD4 wild-type and mutant colorectal cancers or the claimed nonsignificant result; the citing sentence points to its own Figure S5M for that finding. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Lower expression of IKZF2 was associated with poorer prognosis in AML (TCGA analysis).

    “Analysis of the TCGA data showed that the lower expression of IKZF2 was associated with poorer prognosis in AML (Fig. 3d)33.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Goldman, M. J., Craft, B., Hastie, M., Repečka, K., McDade, F., Kamath, A., Banerjee, A., Luo, Y., Rogers, D., Brooks, A. N., Zhu, J., & Haussler, D.
Affiliations
  • University of California, Santa Cruz (US)
  • Vilnius University (LT)
  • Birla Institute of Technology and Science, Pilani - Goa Campus (IN)
  • National Institute of Technology Durgapur (IN)
  • Stanford University (US)
Corresponding author
Goldman, Mary J.
Venue
Nature Biotechnology
Published
2020-05-22
Volume
38
Issue
6
Pages
675-678
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W3028304854
Cited by
4,481
References
20
Citations by year
2026: 540 · 2025: 778 · 2024: 950 · 2023: 771 · 2022: 781 · 2021: 544 · 2020: 108 · 2019: 8
FWCI
198.23
Type
journal article
Language
en
Open access
Locations
  • Nature Biotechnology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (5U24CA180951-04, 5U24CA210974-02)
  • Silicon Valley Community Foundation (2018-182812)
  • Google Summer of Code: https://summerofcode.withgoogle.com/
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genetics, Bioinformatics, and Biomedical Research
Keywords
cancer genomics data, data visualization, data interpretation, genomic databases, cancer genomics
MeSH terms
Humans, Neoplasms, Software, Genomics, Databases, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review